Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Cancer ; 128(2): 342-353, 2023 01.
Article in English | MEDLINE | ID: mdl-36402875

ABSTRACT

BACKGROUND: Survival rates for ovarian cancer remain poor, and monitoring and prediction of therapeutic response may benefit from additional markers. Ovarian cancers frequently overexpress Folate Receptor alpha (FRα) and the soluble receptor (sFRα) is measurable in blood. Here we investigated sFRα as a potential biomarker. METHODS: We evaluated sFRα longitudinally, before and during neo-adjuvant, adjuvant and palliative therapies, and tumour FRα expression status by immunohistrochemistry. The impact of free FRα on the efficacy of anti-FRα treatments was evaluated by an antibody-dependent cellular cytotoxicity assay. RESULTS: Membrane and/or cytoplasmic FRα staining were observed in 52.7% tumours from 316 ovarian cancer patients with diverse histotypes. Circulating sFRα levels were significantly higher in patients, compared to healthy volunteers, specifically in patients sampled prior to neoadjuvant and palliative treatments. sFRα was associated with FRα cell membrane expression in the tumour. sFRα levels decreased alongside concurrent tumour burden in patients receiving standard therapies. High concentrations of sFRα partly reduced anti-FRα antibody tumour cell killing, an effect overcome by increased antibody doses. CONCLUSIONS: sFRα may present a non-invasive marker for tumour FRα expression, with the potential for monitoring patient response to treatment. Larger, prospective studies should evaluate FRα for assessing disease burden and response to systemic treatments.


Subject(s)
Ovarian Neoplasms , Female , Humans , Folate Receptor 1/metabolism , Folate Receptor 1/therapeutic use , Ovarian Neoplasms/pathology , Prospective Studies , Treatment Outcome
2.
J Clin Aesthet Dermatol ; 1(1): 30-3, 2008 May.
Article in English | MEDLINE | ID: mdl-21103307

ABSTRACT

Fractional resurfacing has become a very popular laser modality in recent years, and photodynamic therapy (PDT) has become a mainstay of many practices treating a wide array of clinical entities. In this case report, we describe a recalcitrant verrucous lesion on the foot that is unresponsive to cryotherapy, pulsed dye laser, and pulsed dye laser with PDT. The lesion did, however, respond very well to the use of a fractional laser to enhance the penetration of the PDT photosensitizer and then responded to pulsed dye laser with PDT. Fractional resurfacing prior to PDT may be a novel dermatologic treatment approach, making PDT an even better treatment option in the future.

3.
Neurology ; 64(8): 1438-40, 2005 Apr 26.
Article in English | MEDLINE | ID: mdl-15851738

ABSTRACT

Using T2-weighted MRI, we measured the relative anteroposterior distance of small corona radiata infarcts in 54 patients who had disproportionate weakness in the bulbar (Group A), arm (Group B), and leg (Group C) muscles. The lesions were differently (p < 0.01) located: Group A, most were located anteriorly; Group B, most were in the middle; and Group C, most were located posteriorly. These results suggest that motor fibers are somatotopically arranged in the human corona radiata.


Subject(s)
Cerebral Infarction/pathology , Internal Capsule/pathology , Motor Cortex/pathology , Nerve Fibers, Myelinated/pathology , Pyramidal Tracts/pathology , Adult , Aged , Aged, 80 and over , Arm/innervation , Arm/physiopathology , Ataxia/etiology , Ataxia/pathology , Ataxia/physiopathology , Carotid Stenosis/pathology , Carotid Stenosis/physiopathology , Cerebral Infarction/physiopathology , Diffusion Magnetic Resonance Imaging , Facial Muscles/innervation , Facial Muscles/physiopathology , Female , Humans , Infarction, Middle Cerebral Artery/pathology , Infarction, Middle Cerebral Artery/physiopathology , Internal Capsule/physiology , Leg/innervation , Leg/physiopathology , Male , Middle Aged , Motor Cortex/physiology , Paresis/etiology , Paresis/pathology , Paresis/physiopathology , Pyramidal Tracts/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...